Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Glioblastoma 2 Carcinoma, Basal Cell 2 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rhabdoid Tumor 1 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pinealoma 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Neuroepithelial 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Microphthalmia, Isolated, with Coloboma 5 1 Meningioma 1 Melanoma 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1

Interventions

Fulvestrant 4 palbociclib 3 Letrozole 3 Paclitaxel 2 sonidegib 1 ribociclib 1 irinotecan sucrosofate 1 elacestrant 1 XMT-1522 1 Vorinostat 1 Sirolimus 1 Ritonavir 1 Population Groups 1 Itraconazole 1 Immunotherapy, Adoptive 1 Histone Deacetylase Inhibitors 1 FCN-437c 1 Docetaxel 1 Decitabine 1 Dasatinib 1 Combined Modality Therapy 1 Capecitabine 1 CYH33 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Breast Cancer × sonidegib × Clear all

NCT02027376 2023-04-03

EDALINE

Spanish Breast Cancer Research Group

Phase 1 Completed

12 enrolled 16 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡